Updates
** Cannabis firms' U.S.-listed shares rise between 1% and 7% in afternoon trading
** U.S. President Donald Trump signs executive order recommending the loosening of federal regulations on marijuana
** Cronos Group CRON.O and Aurora Cannabis ACB.O rise 1.1% and 6.7%, respectively
** Tilray Brands TLRY.O jumps 2.5% and Canopy Growth CGC.O surges 3.6%
** The decision to reclassify cannabis as a less dangerous drug does not legalize cannabis, but eases the operating environment for companies by improving access to capital, reducing tax burden and accelerating research and development
** Currently, marijuana, along with LSD and heroin, is a Schedule I controlled substance, meaning it has no currently accepted medical use and a high potential for abuse
(Reporting by Padmanabhan Ananthan, Siddhi Mahatole and Sneha S K)
((Padmanabhan.Ananthan@thomsonreuters.com))